Compare KRYS & STWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRYS | STWD |
|---|---|---|
| Founded | 2015 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 7.4B |
| IPO Year | 2017 | 2009 |
| Metric | KRYS | STWD |
|---|---|---|
| Price | $279.67 | $18.04 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 4 |
| Target Price | ★ $257.45 | $20.63 |
| AVG Volume (30 Days) | 249.5K | ★ 3.4M |
| Earning Date | 02-17-2026 | 02-25-2026 |
| Dividend Yield | N/A | ★ 10.63% |
| EPS Growth | ★ 275.72 | N/A |
| EPS | ★ 6.66 | 1.04 |
| Revenue | $373,164,000.00 | ★ $490,651,000.00 |
| Revenue This Year | $36.10 | $366.38 |
| Revenue Next Year | $42.21 | $12.15 |
| P/E Ratio | $41.50 | ★ $17.36 |
| Revenue Growth | ★ 54.51 | 12.42 |
| 52 Week Low | $122.80 | $16.59 |
| 52 Week High | $295.98 | $21.05 |
| Indicator | KRYS | STWD |
|---|---|---|
| Relative Strength Index (RSI) | 55.88 | 45.85 |
| Support Level | $264.85 | $17.91 |
| Resistance Level | $280.00 | $18.30 |
| Average True Range (ATR) | 11.47 | 0.30 |
| MACD | -1.66 | -0.01 |
| Stochastic Oscillator | 49.97 | 44.19 |
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
Starwood Property Trust Inc is an American real estate investment trust principally engaged in originating, acquiring, and managing commercial mortgage loans and commercial mortgage-backed securities in the U.S. and Europe. The company organizes its activities into Commercial and Residential Lending Segment, Infrastructure Lending Segment, Property Segment, and Investing & Servicing Segment. The company generates the majority of its revenue from the Commercial and Residential Lending Segment, which is engaged in originating, acquiring, financing, and managing commercial first mortgages, and non-agency residential mortgages.